153.3 ð©º å §ç§å°ç§èåç
153.3.0.1 1ïžâ£ Necrotizing Fasciitis èçæµçš
- Suspect (pain out of proportion, crepitus, dusky bullae)
- STAT surgery consult (donât wait for imaging if classic)
- CT/MRI if äžç¢ºå® (gas, fascia involvement)
- Blood cx + tissue cx + Gram stain
- Empirical: vanco + pip-tazo (æ carbapenem) + clindamycin
- ICU resus, vasopressors
- LRINEC score > 6 â high risk
- ± IVIG in toxin-mediated (TSS-like)
153.3.0.2 2ïžâ£ ARF 2° Prophylaxis Duration (Taiwan Heart Association)
| Type | Duration |
|---|---|
| Rheumatic fever + carditis + valvular disease | Until age 40 or life-long |
| Rheumatic fever + carditis, no valvular | 10 yr or until 21 (whichever longer) |
| Rheumatic fever no carditis | 5 yr or until 21 |
Agent: Benzathine PCN G 1.2M IM q3-4wk (é« incidence area 3 wk)
153.3.0.3 3ïžâ£ GBS IAP Indications (USA + Taiwan)
- GBS + (35-37 wk rectovaginal swab)
- åè GBS æ°çå çŸç
- GBS bacteriuria æ¬è
- Unknown GBS + < 37 wk / ROM > 18 hr / temp ⥠38
Agent: PCN G 5M U IV â 2.5M q4h (or amp); allergy â cefazolin
153.3.0.4 4ïžâ£ IE æ²»ç â Viridans vs Enterococcus
- Viridans IE: PCN G alone à 4 wk æ PCN+gent à 2 wk (uncomplicated)
- MIC 0.12-0.5: PCN G + gent à 2 wk æ ceftriaxone à 4 wk
- MIC ⥠0.5 (relatively R): PCN G high-dose + gent à 4 wk
- Prosthetic: Ã 6 wk + gent first 2 wk